The Somatic Genomic Landscape of Glioblastoma

Cited by (1,018)

Items 801–900 of 1,018

1. Dynamic inosinome profiles reveal novel patient stratification and gender-specific differences in glioblastoma
   Domenico Alessandro Silvestris, Ernesto Picardi, Valeriana Cesarini, Bruno Fosso, Nicolò Mangraviti, Luca Massimi, Maurizio Martini, Graziano Pesole, Franco Locatelli, Angela Gallo · 2019 · Genome biology
2. Molecular profiling of long-term IDH-wildtype glioblastoma survivors
   Danielle M. Burgenske, Jie Yang, Paul A. Decker, Thomas M. Kollmeyer, Matthew Kosel, Ann C. Mladek, Alissa A. Caron, Rachael A. Vaubel, Shiv Kumar Gupta, Gaspar J. Kitange et al. · 2019 · Neuro-Oncology
3. Novel Therapies for Glioblastoma
   Elisa K. Liu, Erik P. Sulman, Patrick Yung Wen, Sylvia Christine Kurz · 2020 · Current Neurology and Neuroscience Reports
4. Metabolic heterogeneity and adaptability in brain tumors
   Christian E. Badr, Daniel J. Silver, Florian A. Siebzehnrübl, Loic P. Deleyrolle · 2020 · Cellular and Molecular Life Sciences
5. Decoupling epithelial-mesenchymal transitions from stromal profiles by integrative expression analysis
   Michael P. H. Tyler, Itay Tirosh · 2021 · Nature Communications
6. Uncovering Spatiotemporal Heterogeneity of High-Grade Gliomas: From Disease Biology to Therapeutic Implications
   Andrea Comba, Syed Mohd Faisal, Maria Luisa Varela, Todd Charles Hollon, Wajd N. Al‐Holou, Yoshie Umemura, Felipe Javier Núñez, Sébastien Motsch, Maria Graciela Castro, Pedro Ricardo Lowenstein · 2021 · Frontiers in Oncology
7. Kunitz-type protease inhibitor TFPI2 remodels stemness and immunosuppressive tumor microenvironment in glioblastoma
   Lizhi Pang, Madeline Dunterman, Songlin Guo, Fatima Khan, Yang Liu, Erfan Taefi, Atousa Bahrami, Changiz Geula, Wen-Hao Hsu, Craig Horbinski et al. · 2023 · Nature Immunology
8. Glioblastoma-Infiltrating <i>CD8</i> + T Cells Are Predominantly a Clonally Expanded <i>GZMK</i> + Effector Population
   Wang, Anthony Z., Mashimo, Bryce L., Schaettler, Maximilian O., Sherpa, Ngima D., Leavitt, Lydia A., Livingstone, Alexandra J., Khan, Saad M., Li, Mao, Anzaldua-Campos, Markus I., Bradley, Joseph D. et al. · 2024 · Cancer Discovery
9. Glioblastoma cells increase expression of notch signaling and synaptic genes within infiltrated brain tissue
   Dylan Scott Lykke Harwood, Vilde Pedersen, Nicolai Schou Bager, Ane Yde Schmidt, Tobias Overlund Stannius, Aušrinė Areškevičiūtė, Knud Elnegaard Josefsen, Dorte Schou Nørøxe, David Scheie, Hannah Rostalski et al. · 2024 · Nature Communications
10. Identification of a 6-Cytokine Prognostic Signature in Patients with Primary Glioblastoma Harboring M2 Microglia/Macrophage Phenotype Relevance
    Jinquan Cai, Wei Zhang, Pei Yang, Yinyan Wang, Mingyang Li, Chuanbao Zhang, Zheng Wang, Huimin Hu, Yanwei Liu, Qingbin Li et al. · 2015 · PLoS ONE
11. Genetic Alterations in Gliosarcoma and Giant Cell Glioblastoma
    Ji Eun Oh, Takashi Ohta, Naosuke Nonoguchi, Kaishi Satomi, David Capper, Daniela Pierscianek, Ulrich Sure, Anne Vital, Werner Paulus, Michel Guy André Mittelbronn et al. · 2015 · Brain Pathology
12. Nudt21 regulates the alternative polyadenylation of Pak1 and is predictive in the prognosis of glioblastoma patients
    Yuan Chu, Nathan D. Elrod, Chaojie Wang, Lei Li, Tao Chen, Andrew L. Routh, Zheng Xia, Wei Li, Eric J. Wagner, Ping Ji · 2019 · Oncogene
13. High-resolution structural genomics reveals new therapeutic vulnerabilities in glioblastoma
    Michael J.G. Johnston, Ana Nikolić, Nicoletta Ninkovic, Paul Guilhamon, Florence M.G. Cavalli, Steven Seaman, Franz J. Zemp, John Lee, Aly O. Abdelkareem, Katrina I Ellestad et al. · 2019 · Genome Research
14. Augmented HR Repair Mediates Acquired Temozolomide Resistance in Glioblastoma
    Carlos Rodrigo Gil del Alcazar, Pavlina Krasimirova Todorova, Amyn A. Habib, Bipasha Mukherjee, Sandeep Burma · 2016 · Molecular Cancer Research
15. Circadian regulator NR1D2 regulates glioblastoma cell proliferation and motility
    Min Yu, Wenjing Li, Qianqian Wang, Yan Wang, Fei Lu · 2018 · Oncogene
16. Genetically Engineered T-Cells for Malignant Glioma: Overcoming the Barriers to Effective Immunotherapy
    Pavlina Chuntova, Kira Downey, Bindu Hegde, Neil D. Almeida, Hideho Okada · 2019 · Frontiers in Immunology
17. Tumor Interferon Signaling Is Regulated by a lncRNA INCR1 Transcribed from the PD-L1 Locus
    Marco Mineo, Shawn M. Lyons, Mykola I. Zdioruk, Niklas von Spreckelsen, Rubén Ferrer-Luna, Hirotaka Ito, Quazim A. Alayo, Prakash Kharel, Alexandra Giantini-Larsen, William Y. Fan et al. · 2020 · Molecular Cell
18. A Patient-Derived Cell Atlas Informs Precision Targeting of Glioblastoma
    Patrik Johansson, Cecilia C. Krona, Soumi Kundu, Milena Doroszko, Sathishkumar Baskaran, Linnéa Schmidt, Claire Vinel, Elin Almstedt, Ramy Elgendy, Ludmila Elfineh et al. · 2020 · Cell Reports
19. Adversarial deconfounding autoencoder for learning robust gene expression embeddings
    Ayse B. Dincer, Joseph D. Janizek, Su‐In Lee · 2020 · Bioinformatics
20. Hypoxia-induced GLT8D1 promotes glioma stem cell maintenance by inhibiting CD133 degradation through N-linked glycosylation
    Kun Liu, Liping Jiang, Yulin Shi, Baiyang Liu, Yaomei He, Qiushuo Shen, Xiulin Jiang, Zhi Nie, Jun Pu, Cuiping Yang et al. · 2022 · Cell Death and Differentiation
21. DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patients
    Richard Drexler, Ulrich Schüller, Alicia Eckhardt, Katharina Filipski, Tabea Isabelle Hartung, Patrick N. Harter, Iris Divé, Marie-Thérèse Forster, Marcus Czabanka, Claudius Jelgersma et al. · 2022 · Neuro-Oncology
22. Assessment and prediction of glioblastoma therapy response: challenges and opportunities
    Dan Qi, Jing Li, C. Chad Quarles, Ekokobe Fonkem, Erxi Wu · 2022 · Brain
23. Monocyte-neutrophil entanglement in glioblastoma
    Dinorah Friedmann‐Morvinski, Dolores Hambardzumyan · 2023 · Journal of Clinical Investigation
24. IL-13Rα2/TGF- β bispecific CAR-T cells counter TGF- β -mediated immune suppression and potentiate anti-tumor responses in glioblastoma
    Andrew J. Hou, Ryan M. Shih, Benjamin R. Uy, Amanda M. Shafer, ZeNan L Chang, Begonya Comin-Anduix, Miriam Güemes, Zoran Galić, Su Myat Phyu, Hideho Okada et al. · 2024 · Neuro-Oncology
25. Inference of Ancestral Recombination Graphs through Topological Data Analysis
    Pablo G. Cámara, Arnold J. Levine, Raúl Rabadán · 2016 · PLoS Computational Biology
26. Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance
    Helena Motaln, Ana Koren, Kristina Gruden, Živa Ramšak, Christian Schichor, Tamara T. Lah · 2015 · Oncotarget
27. Targeting hexokinase 2 enhances response to radio-chemotherapy in glioblastoma
    Alenoush Vartanian, Sameer Agnihotri, Mark R. Wilson, Kelly E. Burrell, Peter D. Tonge, Amir Alamsahebpour, Shahrzad Jalali, Michael S. Taccone, Sheila Mansouri, Brian J. Golbourn et al. · 2016 · Oncotarget
28. MicroRNA Signatures and Molecular Subtypes of Glioblastoma: The Role of Extracellular Transfer
    Jakub A. Godlewski, Rubén Ferrer-Luna, Arun Kumar Rooj, Marco Mineo, Franz Lennard Ricklefs, Yuji S. Takeda, Michal Oskar Nowicki, Elżbieta Salińska, Ichiro Nakano, Hakho Lee et al. · 2017 · Stem Cell Reports
29. Dissecting human gliomas by single-cell RNA sequencing
    Itay Tirosh, Mario L. Suvà · 2017 · Neuro-Oncology
30. Comprehensive pancancer genomic analysis reveals (RTK)-RAS-RAF-MEK as a key dysregulated pathway in cancer: Its clinical implications
    Robin John Lester Imperial, Omer M. Toor, Arif Hussain, Janakiraman Subramanian, Ashiq Masood · 2017 · Seminars in Cancer Biology
31. Vemurafenib
    Claus Garbe, Thomas Eigentler · 2018 · Recent results in cancer research/Recent Results in Cancer Research
32. Glioblastoma cellular cross-talk converges on NF-κB to attenuate EGFR inhibitor sensitivity
    Ciro Zanca, Genaro R. Villa, Jorge A. Benítez, Amy Haseley Thorne, Tomoyuki Koga, Matteo D’Antonio, Shiro Ikegami, Jianhui Ma, Antonia D. Boyer, Afsheen Banisadr et al. · 2017 · Genes & Development
33. EGFR/c-myc axis regulates TGFβ/Hippo/Notch pathway via epigenetic silencing miR-524 in gliomas
    Kai Zhao, Qixue Wang, Yunfei Wang, Kai Huang, Chao Yang, Yansheng Li, Kaikai Yi, Chunsheng Kang · 2017 · Cancer Letters
34. Molecular and cellular intratumoral heterogeneity in primary glioblastoma: clinical and translational implications
    Joshua D. Bernstock, James Henry Mooney, Adeel Ilyas, Gustavo Chagoya, Dagoberto Estévez-Ordoñez, Ahmed Gamal Abdellatif Ibrahim, Ichiro Nakano · 2019 · Journal of neurosurgery
35. Computational immunogenomic approaches to predict response to cancer immunotherapies
    Venkateswar Addala, Felicity Newell, John V. Pearson, Alec Redwood, Bruce W.S. Robinson, Jenette Creaney, Nicola Waddell · 2023 · Nature Reviews Clinical Oncology
36. Epidermal Growth Factor Receptor Inhibitors in Glioblastoma: Current Status and Future Possibilities
    Shawyon Ezzati, Samuel Salib, Meenakshisundaram Balasubramaniam, Orwa Aboud · 2024 · International Journal of Molecular Sciences
37. Eph receptors as therapeutic targets in glioblastoma
    Bryan W. Day, Brett William Stringer, Andy Boyd · 2014 · British Journal of Cancer
38. Focal chromosomal copy number aberrations in cancer—Needles in a genome haystack
    Oscar Krijgsman, Beatriz G. Carvalho, Gerrit A. Meijer, Renske D.M. Steenbergen, Bauke Ylstra · 2014 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
39. Epigenetic dysregulation in glioma
    Yutaka Kondo, Keisuke Katsushima, Fumiharu Ohka, Atsushi Natsume, Keiko Shinjo · 2014 · Cancer Science
40. Domino: Extracting, Comparing, and Manipulating Subsets Across Multiple Tabular Datasets
    Samuel Gratzl, Nils Gehlenborg, Alexander Lex, Hanspeter Pfister, Marc Streit · 2014 · IEEE Transactions on Visualization and Computer Graphics
41. Detection of Gene Rearrangements in Targeted Clinical Next-Generation Sequencing
    Haley Abel, Hussam Al‐Kateb, Catherine E. Cottrell, Andrew J. Bredemeyer, Colin C. Pritchard, Allie H. Grossmann, Michelle L. Wallander, John D. Pfeifer, Christina M. Lockwood, Eric James Duncavage · 2014 · Journal of Molecular Diagnostics
42. EphA2 is a key effector of the MEK/ERK/RSK pathway regulating glioblastoma cell proliferation
    Yuho Hamaoka, Masahiko Negishi, Hironori Katoh · 2016 · Cellular Signalling
43. Preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma
    Abhishek Dinkarnath Garg, Lien Vandenberk, Matthias Van Woensel, Jochen Belmans, Marco B.E. Schaaf, Louis Boon, Steven De Vleeschouwer, Patrizia Agostinis · 2017 · OncoImmunology
44. Pegasus: a comprehensive annotation and prediction tool for detection of driver gene fusions in cancer
    Francesco Abate, Sakellarios Zairis, Elisa Ficarra, Andrea Acquaviva, Chris H. Wiggins, Veroniquè Frattini, Anna Lasorella, Antonio Iavarone, Giorgio Inghirami, Raúl Rabadán · 2014 · BMC Systems Biology
45. Prospective of curcumin, a pleiotropic signalling molecule from Curcuma longa in the treatment of Glioblastoma
    Pratibha Mehta Luthra, Neetika Lal · 2015 · European Journal of Medicinal Chemistry
46. Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas
    Ralph Salloum, Melissa K. McConechy, Leonie G. Mikael, Christine E. Fuller, Rachid Drissi, Mariko Dawn DeWire, Hamid Nikbakht, Nicolas De Jay, Xiaodan Yang, Daniel R. Boué et al. · 2017 · Acta Neuropathologica Communications
47. Mesenchymal glioblastoma constitutes a major ceRNA signature in the TGF-β pathway
    Qixue Wang, Jinquan Cai, Chuan Fang, Chao Yang, Junhu Zhou, Yanli Tan, Yunfei Wang, Yansheng Li, Xiangqi Meng, Kai Zhao et al. · 2018 · Theranostics
48. Is there a causal link between PTEN deficient tumors and immunosuppressive tumor microenvironment?
    Vildan Bozok Çetintaş, Nizar N. Batada · 2020 · Journal of Translational Medicine
49. Engineering antibody and protein therapeutics to cross the blood–brain barrier
    Peng Zhao, Ningyan Zhang, Zhiqiang An · 2022 · Antibody Therapeutics
50. Therapeutic Targets in Glioblastoma: Molecular Pathways, Emerging Strategies, and Future Directions
    Justin Tang, Nishika Karbhari, Jian Li Campian · 2025 · Cells
51. AngioMatrix, a signature of the tumor angiogenic switch-specific matrisome, correlates with poor prognosis for glioma and colorectal cancer patients
    Benoît Langlois, Falk Saupe, Tristan Rupp, Christiane Arnold, Michaël van der Heyden, Gertraud Orend, Thomas Hussenet · 2014 · Oncotarget
52. Distinct and separable roles for EZH2 in neurogenic astroglia
    William W. Hwang, Ryan D. Salinas, Jason J. Siu, Kevin W. Kelley, Ryan Nicholas Delgado, Mercedes F. Paredes, Arturo Álvarez-Buylla, Michael C. Oldham, Daniel A. Lim · 2014 · eLife
53. Challenges to targeting epidermal growth factor receptor in glioblastoma: escape mechanisms and combinatorial treatment strategies
    Patrick Roth, Michael Weller · 2014 · Neuro-Oncology
54. Unsupervised deep learning reveals prognostically relevant subtypes of glioblastoma
    Jonathan D. Young, Chunhui Cai, Xinghua Lu · 2017 · BMC Bioinformatics
55. Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma
    Israel López-Valero, Sofía Torres, María Salazar‐Roa, Elena García-Taboada, Sonia Hernández‐Tiedra, Manuel Guzmán, Juan Manuel Sepúlveda-Sánchez, Guillermo Velasco, Mar Lorente · 2018 · Biochemical Pharmacology
56. A comparative study of multi-omics integration tools for cancer driver gene identification and tumour subtyping
    Anita Sathyanarayanan, Rohit Gupta, Erik W. Thompson, Dale R. Nyholt, Denis C. Bauer, Shivashankar Hiriyur Nagaraj · 2019 · Briefings in Bioinformatics
57. Wnt-Induced Stabilization of KDM4C Is Required for Wnt/β-Catenin Target Gene Expression and Glioblastoma Tumorigenesis
    Yaohui Chen, Runping Fang, Chen Yue, Guoqiang Chang, Peng Li, Qing Guo, Jing Wang, Aidong Zhou, Sicong Zhang, Gregory N. Fuller et al. · 2019 · Cancer Research
58. Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients with prior antiangiogenic therapy
    Timothy Francis Cloughesy, Jan Drappatz, John de Groot, Michael D. Prados, David A. Reardon, David Schiff, Marc Charles Chamberlain, Tom Mikkelsen, Annick Desjardins, Jerry Ping et al. · 2017 · Neuro-Oncology
59. Role of SOX family of transcription factors in central nervous system tumors.
    Arlet Acanda de la Rocha, Nicolàs Samprón, Marta María Alonso, Ander Matheu · 2014 · Europe PMC (PubMed Central)
60. Glioblastoma multiforme: novel therapeutic targets
    Matthew T. Muir, Sricharan Gopakumar, Jeffrey Isaac Traylor, Sungho Lee, Ganesh Rao · 2020 · Expert Opinion on Therapeutic Targets
61. Targeting Glioblastoma: Advances in Drug Delivery and Novel Therapeutic Approaches
    Eilam Yeini, Paula Ofek, Nitzan Albeck, Daniel Rodriguez Ajamil, Lena Neufeld, Anat Eldar‐Boock, Ron Kleiner, Daniella Vaskovich‐Koubi, Shani Koshrovski‐Michael, Sahar Israeli Dangoor et al. · 2020 · Advanced Therapeutics
62. Genetic Architectures and Cell-of-Origin in Glioblastoma
    Hyun Jung Kim, Jung‐Won Park, Jeong Ho Lee · 2021 · Frontiers in Oncology
63. Human TERT promoter mutations as a prognostic biomarker in glioma
    Branka Powter, Sarah A. Jeffreys, Heena Sareen, Adam James Cooper, Daniel Brungs, Joseph William Po, Tara Laurine Roberts, Eng‐Siew Koh, Kieran F. Scott, Mila Sajinovic et al. · 2021 · Journal of Cancer Research and Clinical Oncology
64. Understanding Glioblastoma Signaling, Heterogeneity, Invasiveness, and Drug Delivery Barriers
    Nadin Rabah, Fatima-ezzahra Ait Mohand, Nataly Kravchenko‐Balasha · 2023 · International Journal of Molecular Sciences
65. Cell-free therapy based on extracellular vesicles: a promising therapeutic strategy for peripheral nerve injury
    Mojdeh Salehi Namini, Fatemeh Daneshimehr, Nima Beheshtizadeh, Vahid Mansouri, Jafar Ai, Hossein Kargar Jahromi, Somayeh Ebrahimi‐Barough · 2023 · Stem Cell Research & Therapy
66. Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma
    Phillip M. Galbo, Anne Tranberg Madsen, Yang Liu, Mou Peng, Wei Yao, Michael J. Ciesielski, Robert Alan Fenstermaker, Sarah Graff, Cristina Montagna, Jeffrey E. Segall et al. · 2023 · Clinical Cancer Research
67. Principles in the Management of Glioblastoma
    Domingos Roda, Pedro Veiga, Joana Barbosa Melo, Isabel M. Carreira, Ilda Patrícia Ribeiro · 2024 · Genes
68. A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine
    Pauline Latzer, Henning Zelba, Florian Battke, Annekathrin Reinhardt, Borong Shao, Oliver Bartsch, Armin Rabsteyn, Johannes Harter, Martin Schulze, Thomas Okech et al. · 2024 · Nature Communications
69. Aberrant self‐renewal and quiescence contribute to the aggressiveness of glioblastoma
    Benito Campos, Zoltan Gal, Aline Baader, Tilman Schneider, Christopher Sliwinski, Kristina Gassel, Josephine Bageritz, Niels Grabe, Andreas von Deimling, Philipp Beckhove et al. · 2014 · The Journal of Pathology
70. Defining the cutoff value of MGMT gene promoter methylation and its predictive capacity in glioblastoma
    Giovanni Brigliadori, Flavia Foca, Monia Dall’Agata, Claudia Rengucci, Elisabetta Melegari, Serenella Cerasoli, Dino Amadori, Daniele Calistri, Marina Faedi · 2016 · Journal of Neuro-Oncology
71. High-Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML
    Yue Zhao, Qi Liu, Pankaj Acharya, Kristy R. Stengel, Quanhu Sheng, Xiaofan Zhou, Hojoong Kwak, Melissa Ann Fischer, James E. Bradner, Stephen Anthony Strickland et al. · 2016 · Cell Reports
72. A survey and evaluation of Web-based tools/databases for variant analysis of TCGA data
    Zhuo Zhang, Hao Li, Shuai Jiang, Ruijiang Li, Wanying Li, Hebing Chen, Xiaochen Bo · 2018 · Briefings in Bioinformatics
73. IDH1: Linking Metabolism and Epigenetics
    Silvia Raineri, Jane Mellor · 2018 · Frontiers in Genetics
74. The Role of Translocator Protein TSPO in Hallmarks of Glioblastoma
    Laura-Marie Ammer, Arabel Vollmann‐Zwerenz, Viktoria Ruf, Christian H. Wetzel, Markus J. Riemenschneider, Nathalie L. Albert, Philipp Beckhove, Peter Hau · 2020 · Cancers
75. VRK1 is a synthetic-lethal target in VRK2-deficient glioblastoma
    Shields, Julie A., Meier, Samuel R., Bandi, Madhavi, Mulkearns-Hubert, Erin E., Hajdari, Nicole, Ferdinez, Maria Dam, Engel, Justin L., Silver, Daniel J., Shen, Binzhang, Zhang, Wenhai et al. · 2022 · Cancer Research
76. Reverse phase protein arrays in signaling pathways: a data integration perspective
    Shixia Huang, Chad J. Creighton · 2015 · Drug Design Development and Therapy
77. The challenges associated with molecular targeted therapies for glioblastoma
    Toni Rose Jue, Kerrie Leanne McDonald · 2016 · Journal of Neuro-Oncology
78. Upregulation of long noncoding RNA HOXA-AS3 promotes tumor progression and predicts poor prognosis in glioma
    Fan Wu, Chuanbao Zhang, Jinquan Cai, Fan Yang, Tingyu Liang, Xiaoyan Yan, Haoyuan Wang, Wen Wang, Jing Chen, Tao Jiang · 2017 · Oncotarget
79. Suppression of tumor growth via IGFBP3 depletion as a potential treatment in glioma
    Chia‐Hua Chen, Pin‐Yuan Chen, You-Yu Lin, Li-Ying Feng, Shin-Han Chen, Chia‐Yuan Chen, Yin-Cheng Huang, Chiung-Yin Huang, Shih-Ming Jung, Leslie Y. Chen et al. · 2019 · Journal of neurosurgery
80. RETRACTED ARTICLE: Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway
    Zizhuo Li, Yaodong Chen, Tingting An, Pengfei Liu, Jiyuan Zhu, Haichao Yang, Wei Zhang, Tianxiu Dong, Jian Jiang, Yu Zhang et al. · 2019 · Journal of Experimental & Clinical Cancer Research · Retracted
81. The Role of EBV-Induced Hypermethylation in Gastric Cancer Tumorigenesis
    Lyla J. Stanland, Micah A. Luftig · 2020 · Viruses
82. EGFR Regulates the Hippo pathway by promoting the tyrosine phosphorylation of MOB1
    Toshinori Ando, Nadia Arang, Zhiyong Wang, Daniela Elena Costea, Xiaodong Feng, Yusuke Goto, Hiroki Izumi, Mara Gilardi, Kazuyo Ando, Jorge Silvio Gutkind · 2021 · Communications Biology
83. The Evolving Classification of Diffuse Gliomas: World Health Organization Updates for 2021
    Alejandro Perez, Jason T. Huse · 2021 · Current Neurology and Neuroscience Reports
84. Crosstalk between PI3K/AKT/mTOR and WNT/β-Catenin signaling in GBM - Could combination therapy checkmate the collusion?
    Daisy Precilla Senthilathiban, Indrani Biswas, Shreyas S. Kuduvalli, T. S. Anitha · 2022 · Cellular Signalling
85. CEBPD is a master transcriptional factor for hypoxia regulated proteins in glioblastoma and augments hypoxia induced invasion through extracellular matrix-integrin mediated EGFR/PI3K pathway
    Xinggang Mao, Xiaoyan Xue, Rui Lv, Ang Ji, Tingyu Shi, Xiao-yan Chen, Xiaofan Jiang, Xiang Zhang · 2023 · Cell Death and Disease
86. Glioblastoma cell fate is differentially regulated by the microenvironments of the tumor bulk and infiltrative margin
    Claudia Garcia-Diaz, Anni Pöysti, Elisabetta Mereu, Melanie Clements, Lucy J. Brooks, Felipe Gálvez‐Cancino, Simón P. Castillo, Wenhao Tang, Gordon Beattie, Lilas Courtot et al. · 2023 · Cell Reports
87. Ets Factors Regulate Neural Stem Cell Depletion and Gliogenesis in Ras Pathway Glioma
    Joshua J. Breunig, Rachelle Levy, C. Danielle Antonuk, Jéssica Molina, Marina Dutra‐Clarke, Hannah Park, Aslam Abbasi Akhtar, Gi Bum Kim, Terrence Town, Xin Hu et al. · 2015 · Cell Reports
88. Plexin-B2 promotes invasive growth of malignant glioma
    Audrey P. Le, Yong Huang, Sandeep C. Pingle, Santosh Kesari, Huaien Wang, Raymund L.M. Yong, Hongyan Zou, Roland H. Friedel · 2015 · Oncotarget
89. Specific monoclonal antibodies against IDH1/2 mutations as diagnostic tools for gliomas
    Yukinari Kato · 2014 · Brain Tumor Pathology
90. The novel long non-coding RNA TALNEC2, regulates tumor cell growth and the stemness and radiation response of glioma stem cells
    Shlomit Brodie, Hae Kyung Lee, Wei Jiang, Simona Cazacu, Cunli Xiang, Laila Poisson, Indrani Datta, Steve Kalkanis, Doron Ginsberg, Chaya Brodie · 2017 · Oncotarget
91. Genome-wide association study of familial lung cancer
    Jinyoung Byun, Ann G. Schwartz, Christine M. Lusk, Angela S. Wenzlaff, Mariza de Andrade, Diptasri M. Mandal, Colette Gaba, Ping Yang, Ming You, Elena Y. Kupert et al. · 2018 · Carcinogenesis
92. Mechanism and therapeutic potential of tumor-immune symbiosis in glioblastoma
    Pang, Lizhi, Khan, Fatima, Heimberger, Amy B., Chen, Peiwen · 2022 · Trends in Cancer
93. LRP1B deletion is associated with poor outcome for glioblastoma patients
    Émeline Tabouret, Marianne Labussière, Agustí Alentorn, Yohann Schmitt, Yannick Marie, Marc Sanson · 2015 · Journal of the Neurological Sciences
94. Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant Gliomas
    Alessandro Canella, Alessandra M. Welker, Ji Young Yoo, Jihong Xu, Fazly Salleh Abas, Divya Kesanakurti, Prabakaran Nagarajan, Christine E. Beattie, Erik P. Sulman, Joseph Liu et al. · 2017 · Clinical Cancer Research
95. Detection and benchmarking of somatic mutations in cancer genomes using RNA-seq data
    Alexandre Coudray, Anna M. Battenhouse, Philipp Bücher, Vishwanath R. Iyer · 2018 · PeerJ
96. Deep multiomics profiling of brain tumors identifies signaling networks downstream of cancer driver genes
    Hong Wang, Alexander K. Diaz, Timothy I. Shaw, Yuxin Li, Mingming Niu, Ji-Hoon Cho, Barbara S. Paugh, Yang Zhang, Jeffrey M. Sifford, Bing Bai et al. · 2019 · Nature Communications
97. The prognostic role of IDH mutations in homogeneously treated patients with anaplastic astrocytomas and glioblastomas
    Arne Christians, Antonia Adel-Horowski, Rouzbeh Banan, Ulrich Lehmann, Stephan Bartels, Felix Behling, Alonso Barrantes‐Freer, Christine Stadelmann, Veit Rohde, Florian Stockhammer et al. · 2019 · Acta Neuropathologica Communications
98. Variability in estimated gene expression among commonly used RNA-seq pipelines
    Sonali Arora, Siobhan S. Pattwell, Eric C. Holland, Hamid Bolouri · 2020 · Scientific Reports
99. Pathogenetic Features and Current Management of Glioblastoma
    Hong-My Nguyen, Kirsten Guz-Montgomery, Devin B. Lowe, Dipongkor Saha · 2021 · Cancers
100. Spatial analysis of the glioblastoma proteome reveals specific molecular signatures and markers of survival
     Marie Duhamel, Lauranne Drelich, Maxence Wisztorski, Soulaimane Aboulouard, Jean‐Pascal Gimeno, Nina Ogrinc, Patrick Devos, Tristan Cardon, Michael Weller, Fabienne Escande et al. · 2022 · Nature Communications